IFP Advisors’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
CWP
WIM
AHL
DC
LSA
EWA
SS
GI
FFA
IFP Advisors's INMB Position: Q2 2026 in Review
IFP Advisors reduced its INmune Bio (INMB) stake by 0.95% in Q2 2026, selling an estimated $3 and leaving 208 shares worth $339. The position accounts for ﹤0.01% of the portfolio, ranked #4760.
IFP Advisors first reported a position in INMB in Q1 2021 and has held it in 22 quarters since. The position peaked at $6K in Q3 2021. 16 funds tracked by Wall St. Rank hold INMB as of Q2 2026.
- IFP Advisors held 208 shares of INmune Bio worth $339 as of Q2 2026.
- IFP Advisors sold 2 INmune Bio shares in Q2 2026, an estimated $3.
- INmune Bio made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4760 holding.
- IFP Advisors first reported a position in INmune Bio in Q1 2021 and has held it in 22 quarters since.
- IFP Advisors's INmune Bio position peaked at $6K in Q3 2021.
- 16 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.